ASH 2024: Cell Therapy Post Conference Report

ASH 2024: ADC Post-Conference Report

Our ADC experts have screened the abstracts presented at the 66th ASH Annual Meeting, held in San Diego from the 7th to 10th of December 2024, and identified 106 abstracts (90 clinical and 16 preclinical) associated with records on Beacon ADC. These have been analyzed and listed in our Post-Conference Report.

ASH 2024: ADC Abstract Highlights

This post-conference report sample provides a guide to the ADC-relevant abstracts presented at the 2024 ASH Annual Meeting.

Explore a list of each abstract with information on developmental phase, target, asset, disease indication, trial sponsor, and more. Download your free copy today.

Download Report

You May Also Be Interested In…

Webinar date: 14/05/2025

Navigating Payload Innovation and Toxicity Trends in ADC Development

AACR 2025: ADC Pre-Conference Planner

Access Report

ADC Landscape Review

Access Review

View All

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more